期刊文献+

3种药物体外抗细粒棘球蚴原头节作用的比较 被引量:17

COMPARATIVE STUDY ON THREE DRUGS AGAINST ECHINOCOCCUS GRANULOSUS PROTOSCOLECES IN VITRO
下载PDF
导出
摘要 目的 通过比较氧苯达唑、阿苯达唑和阿苯达唑脂质体体外抗细粒棘球蚴原头节作用 ,探讨氧苯达唑抗包虫病的作用。 方法 将氧苯达唑、阿苯达唑和阿苯达唑脂质体分别配成高、中、低浓度加入 RPMI16 4 0培养基中 ,体外培养细粒棘球蚴原头节 ,观察其每天的死亡率 ,直到对照组的头节全部死亡为止。 结果 将相同条件下 3种药物作用原头节的死亡率分别与对照组相比 ,阿苯达唑、氧苯达唑高、中、低浓度组与对照组相比 ,差异均有统计学意义 (P<0 .0 5 ) ;而阿苯达唑脂质体仅在高浓度时与对照组的差别有统计学意义 (P<0 .0 5 )。 结论 氧苯达唑、阿苯达唑和阿苯达唑脂质体均有显著的体外抗细粒棘球蚴原头节作用 ;氧苯达唑体外抗细粒棘球蚴原头节作用与阿苯达唑相当 ,可认为是一种新型抗包虫药 ;阿苯达唑脂质体剂型并未显示出特殊的体外抗原头节作用。 Objective Anti hydatid efficacy for Echinococcus granulosus protoscoleces( Eg PSC) was investigated by using Oxibendazole (OBZ), Albendazole (ABZ) and Liposomal Albendazole (L ABZ) in vitro . Methods Eg PSC was cultured in three drugs concentrations 2 500 ng/ml, 500 ng/ml, 100 ng/ml) of OBZ, ABZ and L ABZ in the RPMI1640 culture media respectively. The mortality in each group was daily counted until 100% Eg PSC death in control. Results Significant difference of Eg PSC mortality was found among these three drugs with various concentrations compared to control group ( P <0.05); In L ABZ group, however the statistical difference was found only in high concentrations( P <0.05). Conclusion The significant anti protoscolece effect for these three drugs was found in our current experiment in vitro . OBZ had the similar anti hydatid effect compared with ABZ in vitro , which could be considered as a potential candidate drug against E. granulosus . L ABZ did not demonstrate the significant effect of anti hydatid Eg PSC in vitro .
出处 《中国寄生虫病防治杂志》 CSCD 2002年第1期35-38,共4页 Chinese Journal of Parasitic Disease Control
基金 国家自然科学基金项目(No.39660081) 国家"九.五"攻关项目(No.96-906A-04-09) 英国文化委员会项目资助
关键词 细粒棘球蚴 原头节 阿苯达唑 氧苯达唑 阿苯达唑脂质体 体外实验 Echinococcus granulosus protoscoleces albendazole oxibendazole liposomal albendazole in vitro
  • 相关文献

参考文献12

  • 1Mottahian H, Saidi F. Post operative recurrence of hydatid disease[J].Br J Surg, 1978, 65:237-42.
  • 2Schiller CF. Complications of echinococcus cyst rupture[J].J Am Med Assoc, 1966, 195:220-2.
  • 3Yasawy MI, Mohamed AE, AL-Karawi MA. Albendazole in hydatid disease: results in 22 patients[J].Annals of Saudi Med, 1992, 12:152-6.
  • 4Mansueto S,Di-Rosa S,Farinella E et al. Albendazole in the treatment of hydatid disease more than a hope[J].Trans R Soc Trop Med Hyg, 1987, 81:168.
  • 5Daris A, Pawlowski ZS, Dixon H. Multicentre clinical trials of benzimidazole carbamates in human echinococcosis[J].Bull WHO, 1986, 64:383.
  • 6Wen H, Zou PF, Yang WG. Albendazole chemotherapy for human cystic and alveolar echinococcosis in north-western China[J]. Trans R Soc Trop Med Hyg,1994,88:340-3.
  • 7徐秉锟.人体寄生虫学[M].第3版.北京:人民卫生出版社, 1990.292.
  • 8Horton RJ. Albendazole in treatment of human cystic echinococcosis:12 years of experience[J].Acta Tropica, 1997, 64:79.
  • 9Wen H, New RRC, Muhmut M, et al. Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine[J]. Parasitology,1996,113:111-21.
  • 10邵英梅,刘文杰,温浩.阿苯达唑脂质体对小鼠细粒棘球蚴囊超微结构的影响[J].中国寄生虫学与寄生虫病杂志,1999,17(5):292-293. 被引量:6

二级参考文献6

共引文献5

同被引文献212

引证文献17

二级引证文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部